Lsv Asset Management Regeneron Pharmaceuticals, Inc. Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$680.49 - $826.97 $1.84 Million - $2.23 Million	-2,700 Reduced 5.18%	49,400 $40.6 Million
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $1.2 Million - $1.3 Million	-1,700 Reduced 3.16%	52,100 $37.6 Million
Q3 2022 Nov 07, 2022	SELL	$573.97 - $724.32 $2.07 Million - $2.61 Million	-3,600 Reduced 6.27%	53,800 $37.1 Million
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $73.7 Million - $99.2 Million	-134,330 Reduced 70.06%	57,400 $33.9 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $5.07 Million - $5.96 Million	-8,527 Reduced 4.26%	191,730 $134 Million
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $5.22 Million - $6.45 Million	-9,610 Reduced 4.58%	200,257 $126 Million
Q3 2021 Nov 04, 2021	SELL	$574.03 - $680.96 $15.2 Million - $18.1 Million	-26,520 Reduced 11.22%	209,867 $127 Million
Q2 2021 Aug 04, 2021	SELL	$472.8 - $558.54 $7.36 Million - $8.69 Million	-15,564 Reduced 6.18%	236,387 $132 Million
Q1 2021 Apr 30, 2021	SELL	$446.73 - $548.2 $5.24 Million - $6.43 Million	-11,731 Reduced 4.45%	251,951 $119 Million
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $16.7 Million - $21.2 Million	-34,930 Reduced 11.7%	263,682 $127 Million
Q3 2020 Oct 23, 2020	SELL	$544.75 - $658.21 $12.5 Million - $15.2 Million	-23,024 Reduced 7.16%	298,612 $167 Million
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $31.3 Million - $40.9 Million	-63,502 Reduced 16.49%	321,636 $201 Million
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $28.2 Million - $41.4 Million	83,818 Added 27.82%	385,138 $188 Million
Q4 2019 Feb 10, 2020	BUY	$274.13 - $376.51 $75.5 Million - $104 Million	275,290 Added 1057.59%	301,320 $113 Million
Q3 2019 Nov 07, 2019	BUY	$273.46 - $318.39 $7.12 Million - $8.29 Million	26,030 New	26,030 $7.22 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account